News
PITTSBURGH, PA, August 1, 2024 – PRISM MediaWire -- Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has closed its previously...

1 August 2024

News
Conference Call and Webcast on Thursday, August 8, 2024 at 2:00 p.m. PT / 5:00 p.m. ET

1 August 2024

News
PITTSBURGH, PA, August 1, 2024 – PRISM MediaWire - Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has entered into a definit...

1 August 2024

News
NEW YORK and SANTA BARBARA, Calif., July 30, 2024 - PRISM MediaWire -  Phytanix Bio, a pioneering preclinical stage pharmaceutical company dedicated to the development of therapeutics based on cannabinoid and cannabinoid-like molecules, today announced the release of its...

30 July 2024

News
Top Line Data Expected Year-End 2024

29 July 2024

Artificial Intelligence:
New York, July 24, 2024 - PRISM MarketView - As artificial intelligence (AI) continues to grow in significance, the infrastructure supporting AI technologies has also evolved. This also opens a new door for opportunities related to AI as investors look to boost portfolio...

24 July 2024

News
IRVINE, CA, June 17, 2024 - PRISM MediaWire - Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, today announced that it has appointed leading finance executive, Andrea James, to the position of Chief Financial Officer.

17 June 2024

News
Clinical testing of LP-310 expected to commence in mid-2024

31 May 2024

News
Abstract highlighting new preclinical data from LP-50 in non-muscle invasive bladder cancer

29 May 2024

News
Company to initiate Phase 2b clinical trial in lead asset, LP-10 in 2H 2024

21 May 2024

1
2
3
4
5
6
7
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.